[Efficiency of use of immunoglobulin preparations for the postexposure prevention of tick-borne encephalitis in Russia (a review of semi-centennial experience)]
- PMID: 20361640
[Efficiency of use of immunoglobulin preparations for the postexposure prevention of tick-borne encephalitis in Russia (a review of semi-centennial experience)]
Abstract
Along with regenerated interest in passive immunization during flavivirus infections, there is an increase in the number of reports with negative opinions as to the expediency of postexposure immunoglobulin prophylaxis (IGP) of tick-borne encephalitis (TBE). Analysis of the publications (since 1959) on this problem has indicated that more than half of them, including all papers with negative opinions as to IGP, contain the results of studies whose design are unsuitable for the solution of the problem associated with the efficiency of medical interventions in the context of evidence-based medicine. Analysis of the results of cohort studies has established that the timely single administration of an immunoglobulin (IG) preparation against TBE in a dose of 0.05 ml/kg body weight ensures protection on average in 79% of cases. Increasing the single dose to 0.1 ml/kg, as re-administration of IG, provides no additional protective effect. The preventive efficacy of IG preparations against TBE varies under the influence of factors, such as the infectious virus dose inoculated from tick suckling, the age of a victim, the antiviral activity of preparations with a antihemagglutinin titer of 1:20 with high infectious virus doses and the absence of reliable rapid tools for its determination on tick suckling, it is necessary to use IG with a titer of at least 1:80 and, desirably, more active in children, for postexposure prophylaxis of TBE.
Similar articles
-
[Metaanalysis of the efficiency of use of immunoglobulin preparations for the postexposure prophylaxis against tick-borne encephalitis in Russia].Med Parazitol (Mosk). 2010 Jul-Sep;(3):58-63. Med Parazitol (Mosk). 2010. PMID: 20873186 Review. Russian. No abstract available.
-
[TBE-immunoglobulins--a critical assessment of efficacy].Schweiz Med Wochenschr. 1994 Oct 22;124(42):1837-40. Schweiz Med Wochenschr. 1994. PMID: 7973509 Review. German.
-
Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.Int J Med Microbiol. 2006 May;296 Suppl 40:195-201. doi: 10.1016/j.ijmm.2006.02.002. Epub 2006 Mar 20. Int J Med Microbiol. 2006. PMID: 16545605
-
A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.Wien Klin Wochenschr. 2002 Jul 31;114(13-14):630-5. Wien Klin Wochenschr. 2002. PMID: 12422616
-
After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment.Vaccine. 2008 Feb 13;26(7):863-8. doi: 10.1016/j.vaccine.2007.11.046. Epub 2007 Dec 4. Vaccine. 2008. PMID: 18206274 Review.
Cited by
-
Inhibitors of tick-borne flavivirus reproduction from structure-based virtual screening.ACS Med Chem Lett. 2013 Jul 30;4(9):869-74. doi: 10.1021/ml400226s. eCollection 2013 Sep 12. ACS Med Chem Lett. 2013. PMID: 24900762 Free PMC article.
-
Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management.World J Clin Cases. 2015 May 16;3(5):430-41. doi: 10.12998/wjcc.v3.i5.430. World J Clin Cases. 2015. PMID: 25984517 Free PMC article. Review.
-
Inapparent Tick-Borne Orthoflavivirus Infection in Macaca fascicularis: A Model for Antiviral Drug and Vaccine Research.Vaccines (Basel). 2023 Nov 25;11(12):1754. doi: 10.3390/vaccines11121754. Vaccines (Basel). 2023. PMID: 38140159 Free PMC article.
-
Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virus.PLoS One. 2019 Apr 8;14(4):e0215075. doi: 10.1371/journal.pone.0215075. eCollection 2019. PLoS One. 2019. PMID: 30958863 Free PMC article.
-
Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease.J Exp Med. 2021 May 3;218(5):e20210236. doi: 10.1084/jem.20210236. J Exp Med. 2021. PMID: 33831141 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical